Curcumin and Cancer: Can It Supplement Chemothera-pies for Cancers?

Message:
Article Type:
Review Article (دارای رتبه معتبر)
Abstract:

Despite advances in knowledge and information on the causes of cancers, prevention, the excellence of diag-nostic systems, and the great achievements of oncology, the incidence of cancer still seems to be on the rise.The used chemical medications, in turn, have shown numerous side effects and cellular toxicity. That is why re-searchers have always been looking for anti-cancer drugs without adverse effects on the patient. Hence, herbalmedicines have received special attention. Curcumin (diferuloylmethane) has been used as a spice in manycountries around the world, including Iran, for centuries. Countless properties of this substance, which is ob-tained from the plant’s root, such as anti-inflammatory, anti-mutagenic, anti-cancer, anti-fungal have been re-ported. This substance is able to affect cell signaling through multiple biochemical pathways, proliferation,differentiation, and cell death. The purpose of writing this review was to examine curcumin and its anti-cancerproperties in a general view for its use in practical medicine.Curcumin, with its epigenetic changes in the level of chromatin, is effective in regulating the expression of majorand regulatory genes and can play a cancer-preventing role in the cell. Also, this substance and its compoundswith inhibition activity of viral protein ACE-2 and Spike glycoprotein of SARS-CoV-2, and regulation of innateimmune response have shown several roles in the fight against diseases.To better understand the mechanism of action of turmeric metabolites with stimulant or inhibitory properties,it is necessary to do more research on the particular effects of Curcumin on various diseases, including cancer,effective dose and how to use it alone or in combination with other drugs.

Language:
English
Published:
Men's health journal, Volume:4 Issue: 1, Winter 2020
Page:
25
magiran.com/p2226197  
دانلود و مطالعه متن این مقاله با یکی از روشهای زیر امکان پذیر است:
اشتراک شخصی
با عضویت و پرداخت آنلاین حق اشتراک یک‌ساله به مبلغ 1,390,000ريال می‌توانید 70 عنوان مطلب دانلود کنید!
اشتراک سازمانی
به کتابخانه دانشگاه یا محل کار خود پیشنهاد کنید تا اشتراک سازمانی این پایگاه را برای دسترسی نامحدود همه کاربران به متن مطالب تهیه نمایند!
توجه!
  • حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران می‌شود.
  • پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانه‌های چاپی و دیجیتال را به کاربر نمی‌دهد.
دسترسی سراسری کاربران دانشگاه پیام نور!
اعضای هیئت علمی و دانشجویان دانشگاه پیام نور در سراسر کشور، در صورت ثبت نام با ایمیل دانشگاهی، تا پایان فروردین ماه 1403 به مقالات سایت دسترسی خواهند داشت!
In order to view content subscription is required

Personal subscription
Subscribe magiran.com for 70 € euros via PayPal and download 70 articles during a year.
Organization subscription
Please contact us to subscribe your university or library for unlimited access!